DR. MARIA FREIRE DELIVERS INAUGURAL PHILIP S. CHEN, JR. LECTURE ON JANUARY 20

["NIH OLIB (NIH/OD)" <olib@xxxxxxxxxx>]

U.S. Department of Health and Human Services

NATIONAL INSTITUTES OF HEALTH

NIH News

Office of the Director (OD)

http://www.nih.gov/icd/od/

Office of Technology Transfer

http://ott.od.nih.gov/index.html

 

FOR IMMEDIATE RELEASE: Tuesday, January 17, 2006

 

CONTACT: NIH Press Office, 301-496-5787

 

DR. MARIA FREIRE DELIVERS INAUGURAL PHILIP S. CHEN, JR. LECTURE ON JANUARY 20

 

WHAT:

The National Institutes of Health announces the inaugural Philip S. Chen, Jr. Distinguished Lecture on Innovation and Technology Transfer.  Maria Freire, Ph.D.,CEO, Global Alliance for TB Drug Development, will present a talk entitled, “Innovation and Collaboration: Revolutionizing TB Therapy.”

 

WHEN:

Friday, January 20, 2006, at 1:30 p.m., Lipsett Auditorium, NIH Building 10, Bethesda, Maryland, USA.  The event is free and open to the public.

 

WHY:

This annual series honors Dr. Philip S. Chen, Jr. for his almost 50 years of service to the National Institutes of Health.   Dr. Chen established NIH's Office of Technology Transfer in 1986 to implement the Federal Technology Transfer Act.  The inventions in the Office of Technology Transfer’s intellectual property portfolio are crucial in advancing the NIH mission --  making important discoveries that improve health and save lives.  Dr. Chen was a researcher in the National Heart Institute from 1956-1959, and has been an administrator in the Intramural Research Program since 1974. The IRP is the largest biomedical research organization in the world.

 

Maria C. Freire, Ph.D., was named Chief Executive Officer of the Global Alliance for TB Drug Development in September 2001.  The TB Alliance is a not-for-profit, public-private partnership created to develop new, faster-acting anti-TB medicines that are affordable and accessible to patients world-wide.  An internationally recognized expert in technology commercialization, Dr. Freire directed the NIH Office of Technology Transfer from 1995 to 2001.  Prior to joining the NIH, Dr. Freire established and headed the Office of Technology Development at the University of Maryland at Baltimore and the University of Maryland, Baltimore County.  She has written and spoken extensively about science in the public interest and how society’s most advanced technologies can be leveraged for global health priorities.  Dr. Freire received a Ph.D. in Biophysics from the University of Virginia and completed post-graduate work in immunology and virology at the University of Virginia and the University of Tennessee, respectively.

 

The National Institutes of Health (NIH) -- "The Nation's Medical Research Agency" -- includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary Federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

 

##

 

This NIH News Release is available online at:

http://www.nih.gov/news/pr/jan2006/od-17.htm.

 

To subscribe (or unsubscribe) from this list, go to

http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.